Source comparison
Hexarelin Dosage Guide: Protocol Comparison
The following table compares three hexarelin administration protocols used in published research, highlighting dose, frequency, duration, and the biological endpoints each design is optimized to measure. | Protocol Type | Dose per Administration | Frequency |
This comparison does not assign a generated winner or score.
- The following table compares three hexarelin administration protocols used in published research, highlighting dose, frequency, duration, and the biological endpoints each design is optimized to measure.
- | Protocol Type | Dose per Administration | Frequency | Study Duration | Primary Endpoint Measured | Desensitization Risk | Professional Assessment ||—|—|—|—|—|—|| Acute Single-Dose | 2mcg/kg (140mcg for 70kg subject) | One-time administration | Single day | Peak GH response, pharmacokinetics, receptor binding kinetics | None (single exposure) | Best for establishing dose-response curves and baseline receptor sensitivity. Not suitable for chronic effect measurement || Twice-Daily Pulsatile | 200–300mcg | Morning and evening (12-hour intervals) | 4–8 weeks | Sustained GH elevation, IGF-1 upregulation, body composition changes | Moderate. Receptor sensitivity maintained for 6–10 weeks with intermittent weekly breaks | Standard protocol for medium-term studies assessing growth hormone axis modulation and downstream anabolic markers || Intermittent Cycling (5 days on, 2 days off) | 200–300mcg | Twice daily during "on" periods | 12–16 weeks | Long-term receptor responsiveness, chronic metab
- Acute protocols are the standard for pharmacokinetic profiling and establishing individual dose-response relationships. Twice-daily continuous protocols produce the most robust short-term effects but face diminishing returns beyond 8 weeks. Intermittent cycling protocols sacrifice consistency for sustainability. Researchers must account for pulsed data patterns and adjust statistical models accordingly, but the tradeoff is maintained effect magnitude across study durations exceeding 3 months.